Vinva Investment Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.1M Buy
53,897
+19,138
+55% +$4.12M 0.14% 167
2025
Q4
$7.2M Buy
34,759
+17,381
+100% +$3.27M 0.09% 184
2025
Q3
$2.69M Buy
17,378
+2,845
+20% +$439K 0.05% 236
2025
Q2
$2.37M Buy
14,533
+12,421
+588% +$1.84M 0.06% 228
2025
Q1
$288K Sell
2,112
-9,859
-82% -$1.26M 0.01% 357
2024
Q4
$1.41M Buy
11,971
+1,181
+11% +$138K 0.05% 258
2024
Q3
$1.18M Buy
10,790
+7,549
+233% +$789K 0.05% 275
2024
Q2
$323K Sell
3,241
-45,488
-93% -$4.64M 0.02% 389
2024
Q1
$5.45M Sell
48,729
-22,721
-32% -$2.45M 0.31% 74
2023
Q4
$7.17M Buy
+71,450
New +$7.09M 0.49% 42
2023
Q3
Sell
-107,946
Closed -$10.1M 362
2023
Q2
$10.1M Buy
107,946
+31,821
+42% +$2.69M 0.87% 20
2023
Q1
$5.74M Buy
+76,125
New +$5.74M 0.48% 51

Other funds holding CAH

Vinva Investment Management's CAH Position: Q1 2026 in Review

Vinva Investment Management increased its Cardinal Health (CAH) stake by 55% in Q1 2026, buying an estimated $4.12M and bringing the position to 53,897 shares worth $11.1M. The position accounts for 0.14% of the portfolio, ranked #167.

Vinva Investment Management first reported a position in CAH in Q1 2023 and has held it in 12 quarters since. 1,431 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • Vinva Investment Management held 53,897 shares of Cardinal Health worth $11.1M as of Q1 2026.
  • Vinva Investment Management bought 19,138 Cardinal Health shares in Q1 2026, an estimated $4.12M.
  • Cardinal Health made up 0.14% of Vinva Investment Management's portfolio in Q1 2026, its #167 holding.
  • Vinva Investment Management first reported a position in Cardinal Health in Q1 2023 and has held it in 12 quarters since.
  • 1,431 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on Vinva Investment Management's 13F filing for Q1 2026, filed 14 May 2026.